This Increased intravenous schooling arm is often built-in into diverse simulation modalities, delivering Positive aspects to activity trainers, manikins, standardized patients and hybrid simulation.; this subsegment is predicted to achieve virtually 50 percent of prescription revenue in 2027 (Show five). We attribute its 8 percent CAGR in revenue